Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months)

NCT00380172 is registered in ClinicalTrials.gov with OccuLogix as lead sponsor.

NCT NCT00380172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00380172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months)
Lead sponsor
OccuLogix
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2005
Completion date
October 31, 2007
Enrollment
120
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration